analyst
TE
NASDAQ · TEM
Tempus AI, Inc.
Healthcare · Medical - Healthcare Information Services
$68.85
Up+$6.64 (+10.67%)
Updated Sep 16, 2026, 9:10 AM
SID Score
6.2/10
Composite research score
Smart Money
56/100
Neutral
- Market cap
- 12.67B
- P/E ratio
- -63.4
- Dividend yield
- 0.00%
- 52-week range
- $40.77 – $104.32
- Volume
- 8.25M
- Avg. volume
- 7M
Price performance
TEM price history
1M range · 20 trading sessions · Daily adjusted prices
TEM closed at $68.85 after 20 trading sessions, up 39.49% for the selected period.
- Last close
- $68.85
- Period change
- +39.49%
- Period low
- $49.36
- Period high
- $72.69
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 15, 2026 | $61.905 | $68.939 | $61.88 | $68.85 | 8.25M |
| Sep 14, 2026 | $57.725 | $62.81 | $57.72 | $62.21 | 4.72M |
| Sep 11, 2026 | $59.47 | $60.38 | $58.48 | $59.01 | 3.69M |
| Sep 10, 2026 | $59.87 | $61.11 | $58.02 | $58.74 | 5.5M |
| Sep 9, 2026 | $63.42 | $64.91 | $60.93 | $61.28 | 6.62M |
| Sep 8, 2026 | $64.04 | $65.79 | $63.21 | $64.29 | 5.2M |
| Sep 4, 2026 | $64.76 | $66.30 | $63.11 | $64.62 | 4.57M |
| Sep 3, 2026 | $63.00 | $64.8131 | $61.19 | $64.66 | 4.92M |
| Sep 2, 2026 | $63.15 | $67.0999 | $60.06 | $61.94 | 5.79M |
| Sep 1, 2026 | $65.64 | $65.79 | $61.22 | $62.27 | 6.24M |
| Aug 31, 2026 | $62.365 | $64.55 | $60.5804 | $63.05 | 7.18M |
| Aug 28, 2026 | $69.045 | $70.8999 | $63.77 | $64.04 | 8.77M |
| Aug 27, 2026 | $68.65 | $71.89 | $67.80 | $70.69 | 6.59M |
| Aug 26, 2026 | $67.48 | $70.2174 | $67.30 | $68.48 | 5.23M |
| Aug 25, 2026 | $66.58 | $70.79 | $63.6101 | $68.73 | 8.88M |
| Aug 24, 2026 | $70.075 | $72.02 | $65.93 | $66.17 | 11.93M |
| Aug 21, 2026 | $65.60 | $72.96 | $65.25 | $72.69 | 15.97M |
| Aug 20, 2026 | $61.83 | $68.96 | $61.70 | $66.65 | 20.14M |
| Aug 19, 2026 | $55.98 | $61.98 | $54.81 | $61.25 | 22.54M |
| Aug 18, 2026 | $50.07 | $51.10 | $49.35 | $49.36 | 3.52M |
Latest TEM news
The latest Smart Investors Daily articles mentioning TEM.
Stock researchCompany · Overview
TEM research
Overview
Company profile and research snapshot.
Company profile
Tempus AI Inc is a technology company. It has built the Tempus Platform, which comprises both a technology platform to free healthcare data from silos and an operating system to make the resulting data useful. Its Intelligent Diagnostics use AI, including generative AI, to make laboratory tests more accurate, tailored, and personal.
Visit company websiteAnalyst outlook
Consensus and target data currently published for this company.
- Consensus
- Buy
- Average target
- $92.14
- Implied upside
- —
- Analysts
- 19
| Date | Firm | Rating | Target |
|---|---|---|---|
| Sep 11, 2026 | HC Wainwright & Co. | Buy | — |
| Sep 9, 2026 | UBS | Neutral | — |
| Sep 8, 2026 | Rothschild & Co | Neutral | — |
| Sep 8, 2026 | Roth Capital | Neutral | — |
| Sep 2, 2026 | Cantor Fitzgerald | Overweight | — |
News briefing
Data unavailable
Market data is busy. Please try again shortly.
AI research layers
Interpretive context generated from the platform’s current data sources.
Data unavailable
Market data is busy. Please try again shortly.